Literature DB >> 25639150

Assembling cyavanaprāsh, Ayurveda's best-selling medicine.

Maarten Bode1.   

Abstract

The paper discusses the many forms and representations of cyavanaprāsh, Ayurveda's best-selling medicine, already mentioned in Caraka's Compendium (c. 200 CE). The medicine's compositions, applications, and meanings, change over time and from locality to locality. Cyavanaprāsh is, for example, a patriotic formula, a booster of the immune system, a modern geriatric drug, and one of the elements in canonical Ayurvedic treatments. In the beginning of the 19th century cyavanaprāsh was a patriotic formula for fortifying Indian bodies and the nascent Indian nation. Nowadays the medicine is a Fast Moving Consumer Good (FMCG) and a money maker for Dabur India Ltd., the world largest Ayurvedic manufacturer. Instead of vitalising the nation its consumption now promises to make urban middle class consumers effectively modern. Branding and modern science must make Dabur Chyawanprash attractive in the eyes of these consumers. Ayurveda and cyavanaprāsh are also part of a global counter culture marked by neo-Orientalism and Ayurvedic medicines as facilitators of spirituality. The marketing of cyavanaprāsh by India's largest Ayurvedic manufacturer is used as a case study for discussing the proliferation of Ayurvedic brands and its critics. The imaging of Ayurvedic brands such as Dabur Chyawanprash threatens to obscure the fact that Ayurveda represents a unique way of looking upon health, disease and the human body. The proliferation of brands also makes Ayurvedic medicines more expensive and puts pressure on the natural environment as the main supplier of Ayurvedic ingredients.

Entities:  

Keywords:  Ayurvedic medicines; India; commodification; counter-culture; direct-to-consumer advertising; health products; orientalism

Mesh:

Substances:

Year:  2015        PMID: 25639150     DOI: 10.1080/13648470.2015.1005285

Source DB:  PubMed          Journal:  Anthropol Med        ISSN: 1364-8470


  3 in total

1.  The transnational Sowa Rigpa industry in Asia: New perspectives on an emerging economy.

Authors:  Stephan Kloos; Harilal Madhavan; Tawni Tidwell; Calum Blaikie; Mingji Cuomu
Journal:  Soc Sci Med       Date:  2019-10-22       Impact factor: 4.634

2.  Classical vs commercial: Is the 'efficacy' of chyawanprash lost when tradition is replaced by modernization?

Authors:  Pradnya Kakodkar; Rohit Sharma; Arati P Dubewar
Journal:  J Ayurveda Integr Med       Date:  2021-11-23

3.  Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study.

Authors:  Arun Gupta; Sunil Kumar; Sanjeeva Dole; Shailesh Deshpande; Vaishali Deshpande; Sudha Singh; V Sasibhushan
Journal:  Anc Sci Life       Date:  2017 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.